Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Scope of the Report:
Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.
The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.
The worldwide market for Meningococcal Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new WMR study.
This report focuses on the Meningococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Quadrivalent
Bivalent
Others
Market Segment by Applications, can be divided into
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccine, with price, sales, revenue and global market share of Meningococcal Vaccine in 2017 and 2018.
Chapter 3, the Meningococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Meningococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Quadrivalent
1.2.2 Bivalent
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Pneumonia
1.3.2 Meningitis
1.3.3 Bacteremia
1.3.4 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Meningococcal Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Meningococcal Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Meningococcal Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 CSL
2.4.1 Business Overview
2.4.2 Meningococcal Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Baxter
2.5.1 Business Overview
2.5.2 Meningococcal Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 JN International Medical Corporation
2.6.1 Business Overview
2.6.2 Meningococcal Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Serum Institute of India
2.7.1 Business Overview
2.7.2 Meningococcal Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bio-Med
2.8.1 Business Overview
2.8.2 Meningococcal Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 China National Biotec Group
2.9.1 Business Overview
2.9.2 Meningococcal Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Hualan Bio
2.10.1 Business Overview
2.10.2 Meningococcal Vaccine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Walvax
2.11.1 Business Overview
2.11.2 Meningococcal Vaccine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Zhifei
2.12.1 Business Overview
2.12.2 Meningococcal Vaccine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Meningococcal Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Meningococcal Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Meningococcal Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Meningococcal Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Meningococcal Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Meningococcal Vaccine Market Analysis by Regions
4.1 Global Meningococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Meningococcal Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Meningococcal Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Meningococcal Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Meningococcal Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Meningococcal Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Meningococcal Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (2014-2019)
5 North America Meningococcal Vaccine by Country
5.1 North America Meningococcal Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Meningococcal Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Meningococcal Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Meningococcal Vaccine Sales and Growth Rate (2014-2019)
6 Europe Meningococcal Vaccine by Country
6.1 Europe Meningococcal Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Meningococcal Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Meningococcal Vaccine Sales and Growth Rate (2014-2019)
6.4 France Meningococcal Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Meningococcal Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Meningococcal Vaccine by Country
7.1 Asia-Pacific Meningococcal Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Meningococcal Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Meningococcal Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Meningococcal Vaccine Sales and Growth Rate (2014-2019)
7.5 India Meningococcal Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
8 South America Meningococcal Vaccine by Country
8.1 South America Meningococcal Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Meningococcal Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Meningococcal Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Meningococcal Vaccine by Countries
9.1 Middle East and Africa Meningococcal Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Meningococcal Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Meningococcal Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Meningococcal Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Meningococcal Vaccine Sales and Growth Rate (2014-2019)
10 Global Meningococcal Vaccine Market Segment by Type
10.1 Global Meningococcal Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Meningococcal Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Quadrivalent Sales Growth and Price
10.2.1 Global Quadrivalent Sales Growth (2014-2019)
10.2.2 Global Quadrivalent Price (2014-2019)
10.3 Bivalent Sales Growth and Price
10.3.1 Global Bivalent Sales Growth (2014-2019)
10.3.2 Global Bivalent Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Meningococcal Vaccine Market Segment by Application
11.1 Global Meningococcal Vaccine Sales Market Share by Application (2014-2019)
11.2 Pneumonia Sales Growth (2014-2019)
11.3 Meningitis Sales Growth (2014-2019)
11.4 Bacteremia Sales Growth (2014-2019)
11.5 Others (Arthritis, Conjunctivitis, Urethritis) Sales Growth (2014-2019)
12 Meningococcal Vaccine Market Forecast (2019-2024)
12.1 Global Meningococcal Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Meningococcal Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Meningococcal Vaccine Market Forecast (2019-2024)
12.2.2 Europe Meningococcal Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Meningococcal Vaccine Market Forecast (2019-2024)
12.2.4 South America Meningococcal Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Meningococcal Vaccine Market Forecast (2019-2024)
12.3 Meningococcal Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Meningococcal Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Meningococcal Vaccine Market Share Forecast by Type (2019-2024)
12.4 Meningococcal Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Meningococcal Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Meningococcal Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Meningococcal Vaccine Picture
Table Product Specifications of Meningococcal Vaccine
Figure Global Sales Market Share of Meningococcal Vaccine by Types in 2018
Table Meningococcal Vaccine Types for Major Manufacturers
Figure Quadrivalent Picture
Figure Bivalent Picture
Figure Others Picture
Figure Meningococcal Vaccine Sales Market Share by Applications in 2018
Figure Pneumonia Picture
Figure Meningitis Picture
Figure Bacteremia Picture
Figure Others (Arthritis, Conjunctivitis, Urethritis) Picture
Figure United States Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure France Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure UK Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure China Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure India Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Meningococcal Vaccine Revenue (Value) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Meningococcal Vaccine Type and Applications
Table Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Meningococcal Vaccine Type and Applications
Table GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Meningococcal Vaccine Type and Applications
Table Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Meningococcal Vaccine Type and Applications
Table CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Meningococcal Vaccine Type and Applications
Table Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table JN International Medical Corporation Basic Information, Manufacturing Base and Competitors
Table JN International Medical Corporation Meningococcal Vaccine Type and Applications
Table JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table Serum Institute of India Meningococcal Vaccine Type and Applications
Table Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bio-Med Basic Information, Manufacturing Base and Competitors
Table Bio-Med Meningococcal Vaccine Type and Applications
Table Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table China National Biotec Group Meningococcal Vaccine Type and Applications
Table China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Meningococcal Vaccine Type and Applications
Table Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Walvax Basic Information, Manufacturing Base and Competitors
Table Walvax Meningococcal Vaccine Type and Applications
Table Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zhifei Basic Information, Manufacturing Base and Competitors
Table Zhifei Meningococcal Vaccine Type and Applications
Table Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Meningococcal Vaccine Sales by Manufacturer (2017-2018)
Figure Global Meningococcal Vaccine Sales Market Share by Manufacturer in 2017
Figure Global Meningococcal Vaccine Sales Market Share by Manufacturer in 2018
Table Global Meningococcal Vaccine Revenue by Manufacturer (2017-2018)
Figure Global Meningococcal Vaccine Revenue Market Share by Manufacturer in 2017
Figure Global Meningococcal Vaccine Revenue Market Share by Manufacturer in 2018
Figure Top 3 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Global Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Global Meningococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Global Meningococcal Vaccine Sales by Regions (2014-2019)
Table Global Meningococcal Vaccine Sales Market Share by Regions (2014-2019)
Table Global Meningococcal Vaccine Revenue by Regions (2014-2019)
Figure Global Meningococcal Vaccine Revenue Market Share by Regions in 2014
Figure Global Meningococcal Vaccine Revenue Market Share by Regions in 2018
Figure North America Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure South America Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure North America Meningococcal Vaccine Revenue and Growth Rate (2014-2019)
Table North America Meningococcal Vaccine Sales by Countries (2014-2019)
Table North America Meningococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Meningococcal Vaccine Sales Market Share by Countries in 2014
Figure North America Meningococcal Vaccine Sales Market Share by Countries in 2018
Table North America Meningococcal Vaccine Revenue by Countries (2014-2019)
Table North America Meningococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Meningococcal Vaccine Revenue Market Share by Countries in 2014
Figure North America Meningococcal Vaccine Revenue Market Share by Countries in 2018
Figure United States Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Canada Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Mexico Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Meningococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Europe Meningococcal Vaccine Sales by Countries (2014-2019)
Table Europe Meningococcal Vaccine Sales Market Share by Countries (2014-2019)
Table Europe Meningococcal Vaccine Revenue by Countries (2014-2019)
Figure Europe Meningococcal Vaccine Revenue Market Share by Countries in 2017
Figure Europe Meningococcal Vaccine Revenue Market Share by Countries in 2018
Figure Germany Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure UK Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure France Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Russia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Italy Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Meningococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Meningococcal Vaccine Sales by Countries (2014-2019)
Table Asia-Pacific Meningococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Meningococcal Vaccine Sales Market Share by Countries 2018
Table Asia-Pacific Meningococcal Vaccine Revenue by Countries (2014-2019)
Figure Asia-Pacific Meningococcal Vaccine Revenue Market Share by Countries 2018
Figure China Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Japan Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Korea Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure India Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure South America Meningococcal Vaccine Revenue and Growth Rate (2014-2019)
Table South America Meningococcal Vaccine Sales by Countries (2014-2019)
Table South America Meningococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure South America Meningococcal Vaccine Sales Market Share by Countries in 2018
Table South America Meningococcal Vaccine Revenue by Countries (2014-2019)
Table South America Meningococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure South America Meningococcal Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Argentina Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Colombia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Meningococcal Vaccine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Meningococcal Vaccine Sales by Countries (2014-2019)
Table Middle East and Africa Meningococcal Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Meningococcal Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Meningococcal Vaccine Revenue by Countries (2014-2019)
Table Middle East and Africa Meningococcal Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Meningococcal Vaccine Revenue Market Share by Countries in 2014
Figure Middle East and Africa Meningococcal Vaccine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure UAE Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Egypt Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure Nigeria Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Figure South Africa Meningococcal Vaccine Sales and Growth Rate (2014-2019)
Table Global Meningococcal Vaccine Sales by Type (2014-2019)
Table Global Meningococcal Vaccine Sales Share by Type (2014-2019)
Table Global Meningococcal Vaccine Revenue by Type (2014-2019)
Table Global Meningococcal Vaccine Revenue Share by Type (2014-2019)
Figure Global Quadrivalent Sales Growth (2014-2019)
Figure Global Quadrivalent Price (2014-2019)
Figure Global Bivalent Sales Growth (2014-2019)
Figure Global Bivalent Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Meningococcal Vaccine Sales by Application (2014-2019)
Table Global Meningococcal Vaccine Sales Share by Application (2014-2019)
Figure Global Meningitis Sales Growth (2014-2019)
Figure Global Bacteremia Sales Growth (2014-2019)
Figure Global Others (Arthritis, Conjunctivitis, Urethritis) Sales Growth (2014-2019)
Figure Global Meningococcal Vaccine Sales, Revenue and Growth Rate (2019-2024)
Table Global Meningococcal Vaccine Sales Forecast by Regions (2019-2024)
Table Global Meningococcal Vaccine Market Share Forecast by Regions (2019-2024)
Figure North America Sales Meningococcal Vaccine Market Forecast (2019-2024)
Figure Europe Sales Meningococcal Vaccine Market Forecast (2019-2024)
Figure Asia-Pacific Sales Meningococcal Vaccine Market Forecast (2019-2024)
Figure South America Sales Meningococcal Vaccine Market Forecast (2019-2024)
Figure Middle East and Africa Sales Meningococcal Vaccine Market Forecast (2019-2024)
Table Global Meningococcal Vaccine Sales Forecast by Type (2019-2024)
Table Global Meningococcal Vaccine Market Share Forecast by Type (2019-2024)
Table Global Meningococcal Vaccine Sales Forecast by Application (2019-2024)
Table Global Meningococcal Vaccine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
Executive Summary
Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...
Overview of the Global Vaccine Supply Chain Solutions Market:
The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...
Overview of the Global Digital Vaccine Tracking System Market:
The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...
The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...